This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

5 Stocks Insiders Are Loading Up On

Alexza Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Another stock in the biotechnology and drugs complex that insiders are buying up a notable amount of is Alexza Pharmaceuticals (ALXA), which is focused on the research, development, and commercialization of products for the acute treatment of central nervous system conditions. Insiders are buying into weakness here since this stock is off by 10% so far in 2012.

Alexza has a market cap of $53.4 million and an enterprise value of $38.7 million. This stocks trades at a price-to-sales of 1.17. Its estimated growth rate for the next quarter is 21.4%, and for next year it's pegged at 22.4%. This is a cash-rich company, with a total cash position on its balance sheet of $28.32 million and total debt of $13.64 million. After you back out the debt, Alexza has $14.68 million in cash on the books.

A beneficial owner just bought 179,041 shares, or about $145,000 worth of stock, at 80 cents per share. It looks like this purchase was part of a private placement for Occitan Capital management, which is a 10% owner of Alexza.

From a technical standpoint, ALXA is currently trading below both its 50-day and 200-day moving averages, which is bearish. This stock dropped from its November high of $1.48 to a recent low of 51 cents per share. After hitting that low, the stock has rebounded to a recent high of 99 cents, and it now trades t around 73 cents.

If you're a bullish on ALXA, then I would consider looking for long-biased trades once this stock breaks out above 80 cents per shares with big volume. Look for volume that's near or well above its three-month average action of 1.02 million shares. You could also buy it off any weakness and anticipate the breakout with a mental stop just below 70 cents per share. I would then add to any long positions once ALXA takes out its 50-day moving average of 89 cents per share with heavy volume.

Stock quotes in this article: NIHD, ZIOP, ALXA, FGP, CHTP 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,262.56 +89.32 0.55%
S&P 500 1,842.98 +12.37 0.68%
NASDAQ 4,034.1610 +11.4670 0.29%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs